Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 November 2018 | Story Xolisa Mnukwa | Photo Johan Roux
Graduation
End-of-year graduation ceremonies kicks-off today.


Livestream

Graduation is the highlight of the academic calendar, and the University of the Free State (UFS) stands by to awarding  its last batch of degrees for the year with the December Graduations which started yesterday.

Kovsie family and friends will be congratulating 173 masters and doctoral graduates in the upcoming ceremonies, and confer more than a thousand certificates, diplomas, undergraduate and honours degrees during the graduation processes.

Speaking at the upcoming processions will be Dr Anchen Laubscher: Group Medical Director of Netcare Ltd, and chair of the Hospital Association of South Africa (HASA) subcommittee for Clinical Quality.

Graduates can further look forward to the likes of Dan Kriek: President of Agri SA, and Danie Meintjes: former Group Chief Executive Officer at Mediclinic International plc, and Non-Executive Director of the Mediclinic International Board.

Author and Chancellor’s Distinguished Young Alumnus of the year 2018, Ace Moloi will also address the audience and bestow words of praise and encouragement as their food for thought.

Graduates can likewise expect speeches from Dr Millard Arnold who belts careers in law, business, diplomacy, journalism, film, and photography to name a few.

Lesedi Makhurane: former Director of Organisational Development at the University of Cape Town (UCT) and University Executive Development (USB-ED) lecturer at the Stellenbosch University will through his speech, endorse the notion of resilience amongst graduates and propel them to live a purpose-driven life.

Visit the graduation home page, where future graduates can in addition access the graduation career guide.  Additional enquiries can be made by emailing graduations@ufs.ac.za

Graduation ceremonies for various faculties will be taking place on the following dates:

4 December 2018
09:00 Economic and Management Sciences, Education 
EMS and EDU Graduation Programme

14:30 South Campus: Open Distance Learning
South Campus Graduation Programme

5 December 2018
09:00 The Humanities, Theology and Religion
HUM and THEO Graduation Programme

14:30  Law, Natural and Agricultural Sciences
LAW and NAS Graduation Programme

6 December 2018
09:00: Health Sciences (including School of Nursing)
Health Sciences Graduation Programme

14:30: Master's and Doctorates (all faculties)
M and D Graduation Programme

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept